metformin has been researched along with Bone Demineralization, Pathologic in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Bone Demineralization, Pathologic: Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. (From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed, pp327-33)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the anti-osteoporosis and anti-diabetes effects and potential underlying mechanisms of treatment with metformin and alendronate in diabetes mellitus mice." | 8.12 | The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice. ( Chen, H; Guan, Z; Han, G; Jin, X; Liu, S; Tao, K; Xuan, Y; Zhou, Q, 2022) |
| "To explore the anti-osteoporosis and anti-diabetes effects and potential underlying mechanisms of treatment with metformin and alendronate in diabetes mellitus mice." | 4.12 | The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice. ( Chen, H; Guan, Z; Han, G; Jin, X; Liu, S; Tao, K; Xuan, Y; Zhou, Q, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Q | 1 |
| Guan, Z | 2 |
| Liu, S | 1 |
| Xuan, Y | 1 |
| Han, G | 1 |
| Chen, H | 1 |
| Jin, X | 1 |
| Tao, K | 1 |
1 other study available for metformin and Bone Demineralization, Pathologic
| Article | Year |
|---|---|
The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice.
Topics: Alendronate; Animals; Blood Glucose; Bone Demineralization, Pathologic; Bone Density; Bone Density C | 2022 |